|
PDCD10 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.03840000223954E-08 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.51137999999662E-05 |
| Normal-vs-Stage2 |
1.70225999999163E-05 |
| Normal-vs-Stage3 |
6.21390000010713E-07 |
| Normal-vs-Stage4 |
1.69286999999185E-05 |
| Stage1-vs-Stage2 |
4.939600E-02 |
| Stage1-vs-Stage3 |
1.854830E-01 |
| Stage1-vs-Stage4 |
1.376950E-01 |
| Stage2-vs-Stage3 |
3.568800E-01 |
| Stage2-vs-Stage4 |
6.727800E-01 |
| Stage3-vs-Stage4 |
6.517200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.80579999953245E-07 |
| Normal-vs-AfricanAmerican |
1.056540E-03 |
| Normal-vs-Asian |
2.078700E-03 |
| Caucasian-vs-AfricanAmerican |
8.576600E-01 |
| Caucasian-vs-Asian |
8.244600E-01 |
| AfricanAmerican-vs-Asian |
9.734200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.66699999973419E-07 |
| Normal-vs-Female |
3.07670000032623E-07 |
| Male-vs-Female |
3.135200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.019600E-04 |
| Normal-vs-Age(41-60Yrs) |
4.46860000113958E-08 |
| Normal-vs-Age(61-80Yrs) |
1.96270000252241E-08 |
| Normal-vs-Age(81-100Yrs) |
2.101600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.790000E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.823540E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.307400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.909800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.919200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.474000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.516000E-01 |
| Classical-VS-Follicular |
5.644000E-03 |
| Classical-VS-Other |
5.558400E-01 |
| Classical-VS-Normal |
1.422260E-04 |
| Tall-VS-Follicular |
1.011850E-02 |
| Tall-VS-Other |
3.855800E-01 |
| Tall-VS-Normal |
3.100100E-02 |
| Follicular-VS-Other |
6.780200E-01 |
| Follicular-VS-Normal |
8.03199999843685E-08 |
| Other-VS-Normal |
1.670780E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.86269999214295E-09 |
| Normal-vs-N1 |
1.560420E-04 |
| N0-vs-N1 |
9.168400E-01 |
|
|
